Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restasis for Dry Eye Symptoms Following LASIK or PRK
NCT00349440Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2006
- Primary completion
- Sep 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in dry eye syndrome (DED), sponsored by Janssen Pharmaceutical. Started Sep 2006; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00349440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349440.